Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
PubMed
Paper Journal Title
Hepatology
Paper Citation Count
63
Paper Publication Year
2011
Bio Mention
HCV, HCV2, Hb, ITPA, ITPA polymorphisms, ITPA variants, ITPase, ITPase deficiency, Inosine, Inosine triphosphatase, PEG, PEG-IFN-2b, Patients, RBV, anemia, hemoglobin, hemolytic anemia, hepatitis, hepatitis C virus, inosine, inosine triphosphatase, inosine triphosphatase (ITPA) gene, inosine triphosphatase (ITPase) deficiency, patients, pegylated interferon alfa-2b, ribavirin, rs1127354, rs7270101
Mesh Descriptor
Go
Actions
Column Actions
Search
Datasets